Abogen Biosciences

Abogen Biosciences, established in 2019 and headquartered in Jiangsu, China, specializes in the development of nucleic acid-based therapeutics, including RNA and DNA treatments, for combating cancer and infectious diseases.

Bo Ying

Founder and CEO

1 past transactions

Zhenzhi Yixue Keji

Seed Round in 2021
Zhenzhi Yixue Keji is a tumor immunotherapy technology developer.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.